Table 4 Persistence with initial treatment in different studies
Duration | ARBs | ACEi | CCBs | BBs | Diuretics | |
|---|---|---|---|---|---|---|
Bloom[15] | 12 | 64% | 58%*** | 50% | 43% | 38% |
Conlin[18] | 48 | 50.9% | 46.5% | 40.7%** | 34.7%** | 16.4%** |
Hasford[36] | 12 | 51.3% | 42.0% | 43.6% | 49.7% | 34.4% |
Degli-Esposti[23] | 12 | 41.7% | 32.2% | 26.7% | 36.9% | 25.9% |
Erkens[37] | 12 | 62.0% | 59.7% | 34.7% | 35.0% | 33.0% |
Veronesi[19] | 24 | 68.5% | 64.5% | 51.6%** | 44.8%** | 34.4%* |
Hasford[17] | 12 | 26.4% | 28.2% | 25.9% | 25.8% | 21.9% |
Patel[16] | 12 | 51.9% | 48.0% | 38.3% | 40.3% | 29.9% |